A white paper from performance.io, built on joint research with Semrush, finds that organic rank still predicts which pharmaceutical pages Google’s AI Overviews cite. Matt Lowe, the agency’s founder and CEO, summarized the work in a contributor piece for Search Engine Land. The dataset spans four years of American drug-search activity.

Pharmaceutical brand sites took 9.2% of first-place organic rankings, yet drew only 4.2% of AI Overview citations. Some 84% of citations came from pages in the organic top 10, and 69% of first-ranked pages earned one. The link was stronger for brands’ own keywords. YouTube supplies around 23% of citations across the wider web but 1.8% in pharma searches.

Read the evidence with its origin in mind. The authors are a vendor and its data partner, and Semrush also owns the publication that ran the piece. Lowe also says the research does not show that compliance rules or source neutrality explain the citation gap.

Pharma search teams should compare top-ranking pages with AI Overview sources for priority queries, and track citations beside positions, since neither step guarantees a citation.

Search Engine Land, contributor article by Matt Lowe, November 18, 2026.